Relative Risk of Probabilistic Category Learning Deficits in Patients with Schizophrenia and Their Siblings

Biological Psychiatry

Volumn 67, Issue 10, 2010, Pages 948-955

  Weickert, Thomas W ^a,b,c   Goldberg, Terry E ^a,d   Egan, Michael F ^a   Apud, Jose A ^a   Meeter, Martijn ^e   Myers, Catherine E ^f,g   Gluck, Mark A ^h   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d ZUCKER HILLSIDE HOSPITAL   (United States)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

^f RUTGERS UNIVERSITY   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h RUTGERS UNIVERSITY   (United States)

Author keywords

Antipsychotics; caudate nucleus; cognition; probability learning; relative risk; schizophrenia

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LEARNING; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SIBLING;

ADULT; FEMALE; HUMANS; INTELLIGENCE; LEARNING DISORDERS; MALE; PROBABILITY LEARNING; RISK; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SIBLINGS;

EID: 77951652938     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.12.027     Document Type: Article

References (70)

1. Knowlton B.J., Squire L.R., and Gluck M.A. Probabilistic classification learning in amnesia. Learn Mem 1 (1994) 106-120
2. Knowlton B.J., Mangels J.A., and Squire L.R. A neostriatal habit learning system in humans. Science 273 (1996) 1399-1402
3. Knowlton B.J., Squire L.R., Paulsen J.S., Swerdlow N.R., Swenson M., and Butters N. Dissociations with nondeclarative memory in Huntington's disease. Neuropsychology 10 (1996) 538-548
4. Fera F., Weickert T.W., Goldberg T.E., Tessitore A., Hariri A., Das S., et al. Neural mechanisms underlying probabilistic category learning in normal aging. J Neurosci 25 (2005) 11340-11348
5. Poldrack R.A., Clark J., Pare-Blagoev E.J., Shohamy D., Creso Moyano J., Myers C., and Gluck M.A. Interactive memory systems in the human brain. Nature 414 (2001) 546-550
6. Poldrack R.A., Prabhakaran V., Seger C.A., and Gabrieli J.D. Striatal activation during acquisition of a cognitive skill. Neuropsychology 13 (1999) 564-574
7. Weickert T.W., Goldberg T.E., Callicott J.H., Chen Q., Apud J.A., Das S., et al. Neural correlates of probabilistic category learning in patients with schizophrenia. J Neurosci 29 (2009) 1244-1254
8. Bustini M., Stratta P., Daneluzzo E., Pollice R., Prosperini P., and Rossi A. Tower of Hanoi and WCST performance in schizophrenia: Problem-solving capacity and clinical correlates. J PsychiatrRes 33 (1999) 285-290
9. Goldberg T.E., Saint-Cyr J.A., and Weinberger D.R. Assessment of procedural learning and problem solving in schizophrenic patients by Tower of Hanoi type tasks. J Neuropsychiatr Clin Neurosci 2 (1990) 165-173
10. Gras-Vincendon A., Danion J.M., Grange D., Bilik M., Willard-Schroeder D., Sichel J.P., and Singer L. Explicit memory, repetition priming and cognitive skill learning in schizophrenia. Schizophr Res 13 (1994) 117-126
11. Michel L., Danion J.M., Grange D., and Sandner G. Cognitive skill learning and schizophrenia: Implications for cognitive remediation. Neuropsychology 12 (1998) 590-599
12. Butters N., Wolfe J., Martone M., Granholm E., and Cermak L.S. Memory disorders associated with Huntington's disease: Verbal recall, verbal recognition and procedural memory. Neuropsychologia 23 (1985) 729-743
13. Martone M., Butters N., Payne M., Becker J.T., and Sax D.S. Dissociations between skill learning and verbal recognition in amnesia and dementia. Arch Neurol 41 (1984) 965-970
14. Phillips L.H., Wynn V., Gilhooly K.J., Della Sala S., and Logie R.H. The role of memory in tower of London task. Memory 7 (1999) 209-231
15. Welsh M.C., Satterlee-Cartmell T., and Stine M. Towers of Hanoi and London: Contribution of working memory and inhibition to performance. Brain Cogn 41 (1999) 231-242
16. Winter W.E., Broman M., Rose A.L., and Reber A.S. The assessment of cognitive procedural learning in amnesia: Why the tower of Hanoi has fallen down. Brain Cogn 45 (2001) 79-96
17. Gold J.M., Hahn B., Strauss G.P., and Waltz J.A. Turning it upside down: Areas of preserved cognitive function in schizophrenia. Neuropsychol Rev 19 (2009) 294-311
18. Keri S., Kelemen O., Szekeres G., Bagoczky N., Erdelyi R., Antal A., et al. Schizophrenics know more than they can tell: Probabilistic classification learning in schizophrenia. Psychol Med 30 (2000) 149-155
19. Murray G.K., Corlett P.R., Clark L., Pessiglione M., Blackwell A.D., Honey G., et al. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry 13 (2008) 267-276
20. Horan W.P., Green M.F., Knowlton B.J., Wynn J.K., Mintz J., and Nuechterlein K.H. Impaired implicit learning in schizophrenia. Neuropsychology 22 (2008) 606-617
21. Johnston D.W., and Bursill A.E. Probability learning and width of attention in normal and schizophrenic groups. Br J Soc Clin Psych 12 (1973) 402-410
22. Keri S., Juhasz A., Rimanoczy A., Szekeres G., Kelemen O., Cimmer C., et al. Habit learning and the genetics of the dopamine D3 receptor: Evidence from patients with schizophrenia and healthy controls. Behav Neurosci 119 (2005) 687-693
23. Weickert T.W., Terrazas A., Bigelow L.B., Malley J.D., Hyde T., Egan M.F., et al. Habit and skill learning in schizophrenia: Evidence of normal striatal processing with abnormal cortical input. Learn Mem 9 (2002) 430-442
24. Foerde K., Poldrack R.A., Knowlton B.J., Sabb F.W., Bookheimer S.Y., Bilder R.M., et al. Selective cortical dysfunction in schizophrenia: Examination of motor and cognitive skill learning. Neuropsychology 22 (2008) 100-109
25. Gluck M.A., Shohamy D., and Myers C. How do people solve the "weather prediction" task?: Individual variability in strategies for probabilistic category learning. Learn Mem 9 (2002) 408-418
26. Lohmam D.F. Minding our p's and q's: On finding relationships between learning and intelligence. In: Ackerman P.L., Kyllonen P.C., and Roberts R.D. (Eds). Learning and Individual Differences: Process, Trait and Content Determinants (1999), American Psychological Association, Washington DC
27. Joel D., Zohar O., Afek M., Hermesh H., Lerner L., Kuperman R., et al. Impaired procedural learning in obsessive-compulsive disorder and Parkinson's disease, not in major depressive disorder. Behav Brain Res 157 (2005) 253-263
28. Rempfer M., Hamera E., Brown C., and Bothwell R.J. Learning proficiency on the Wisconsin card sorting test in people with serious mental illness: What are the cognitive characteristics of good learners?. Schizophr Res 87 (2006) 316-322
29. Schonberg T., Daw N.D., Joel D., and O'Doherty J.P. Reinforcement learning signals in the human striatum distinguish learners from nonlearners during reward-based decision making. J Neurosci 27 (2007) 12860-12867
30. Wiedl K.H. Rehab rounds: Cognitive modifiability as a measure of readiness for rehabilitation. Psychiatr Serv 50 (1999) 1411-1413 1419
31. Wiedl K.H., Wienöbst J., Schöttke H.H., Green M.F., and Nuechterlein K.H. Attentional characteristics of schizophrenia patients differing in learning proficiency on the Wisconsin card sorting test. Schizophr Bull 27 (2001) 687-695
32. Egan M.F., Goldberg T.E., Gscheidle T., Weirich M., Rawlings R., Hyde T.M., et al. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry 50 (2001) 98-107
33. Missar C.D., Gold J.M., and Goldberg T.E. WAIS-R short forms in chronic schizophrenia. Schizophr Res 12 (1994) 247-250
34. Egan M.F., Hyde T.M., Bonomo J.B., Mattay V.S., Bigelow L.B., Goldberg T.E., and Weinberger D.R. Relative risk of neurological signs in siblings of patients with schizophrenia. Am J Psychiatry 158 (2001) 1827-1834
35. Meeter M., Myers C.E., Shohamy D., Hopkins R.O., and Gluck M.A. Strategies in probabilistic categorization: Results from a new way of analyzing performance. Learn Mem 13 (2006) 230-239
36. Cross A.J., Crow T.J., and Owen F. 3H-flupenthixol binding in post-mortem brains of schizophrenics: Evidence for a selective increase in dopamine D2 receptors. Psychopharmacology 74 (1981) 122-124
37. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.A., Erdos J., et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A 93 (1996) 9235-9240
38. Lindstrom L.H., Gefvert O., Hagberg G., Lundberg T., Bergstrom M., Hartvig P., and Langstrom B. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. Biol Psychiatry 46 (1999) 681-688
39. Pilowsky L.S., Costa D.C., Ell P.J., Verhoeff N.P., Murray R.M., and Kerwin R.W. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerized tomography study. Br J Psychiatry 164 (1994) 16-26
40. Seeman P., Guan H.C., and Niznik H.B. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain. Synapse 3 (1989) 96-97
41. Seeman P., and Niznik H.B. Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J 4 (1990) 2737-2744
42. Cole J.O., Klerman G.L., Goldberg S.C., Clyde D.J., Davidson E.M., Kayce M.M., et al. Phenothiazine treatment in acute schizophrenia. Arch Gen Psychiatry 10 (1964) 246-261
43. Crow T.J., and Gillbe C. Brain dopamine and behaviour. A critical analysis of the relationship between dopamine antagonism and therapeutic efficacy of neuroleptic drugs. J Psychiatr Res 11 (1974) 16372
44. Horn A.S., and Snyder S.H. Chlorpromazine and dopamine: Conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proc Natl Academy Sci U S A 68 (1971) 2325-2328
45. Kapur S., and Seeman P. Does fast dissociation from the dopamine D(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry 158 (2001) 360-369
46. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1 (1987) 133-152
47. Bertolino A., Esposito G., Callicott J.H., Mattay V.S., VanHorn J.D., Frank J.A., et al. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry 157 (2000) 26-33
48. Bertolino A., Knable M.B., Saunders R.C., Callicott J.H., Kolachana B., Mattay V.S., et al. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia [see comments]. Biol Psychiatry 45 (1999) 660-667
49. Heinz A., Knable M.B., Coppola R., Gorey J.G., Jones D.W., Lee K.S., and Weinberger D.R. Psychomotor slowing, negative symptoms and dopamine receptor availability-an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients. Schizophr Res 31 (1998) 19-26
50. Meyer-Lindenberg A., Miletich R.S., Kohn P.D., Esposito G., Carson R.E., Quarantelli M., et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5 (2002) 267-271
51. Pickar D., Su T.P., Weinberger D.R., Coppola R., Malhotra A.K., Knable M.B., et al. Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients. Am J Psychiatry 153 (1996) 1571-1578
52. Callicott J.H., Mattay V.S., Verchinski B.A., Marenco S., Egan M.F., and Weinberger D.R. Complexity of prefrontal cortical dysfunction in schizophrenia: More than up or down. Am J Psychiatry 160 (2003) 2209-2215
53. Manoach D.S., Gollub R.L., Benson E.S., Searl M.M., Goff D.C., Halpern E., et al. Schizophrenia subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 48 (2000) 99-109
54. Molina V., Sanz J., Sarramea F., and Palomo T. Marked hypofrontality in clozapine-responsive patients. Pharmacopsychiatry 40 (2007) 157-162
55. Buchsbaum M.S., Buchsbaum B.R., Hazlett E.A., Haznedar M.M., Newmark R., Tang C.Y., and Hof P.R. Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry 164 (2007) 1072-1081
56. Glenthoj A., Glenthoj B.Y., Mackeprang T., Pagsberg A.K., Hemmingsen R.P., Jernigan T.L., and Baaré W.F. Basal ganglia volumes in drug-naïve, first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res 154 (2007) 199-208
57. Goldman A.L., Pezawas L., Mattay V.S., Fischl B., Verchinski B.A., Zoltick B., et al. Heritability of brain morphology related to schizophrenia: A large-scale, automated magnetic resonance imaging segmentation study. Biol Psychiatry 63 (2008) 475-483
58. Hoptman M.J., Volavka J., Czobor P., Gerig G., Chakos M., Blocher J., et al. Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder. J Neuropsychiatr Clin Neurosci 28 (2006) 509-515
59. McClure R.K., Phillips I., Jazayerli R., Barnett A., Coppola R., and Weinberger D.R. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment. Psychiatry Res 148 (2006) 121-132
60. Okugawa G., Nobuhara K., Takase K., Saito Y., Yoshimura M., and Kinoshita T. Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia. Neuropsychobiology 55 (2007) 43-46
61. vanHaren N.E., Hulshoff Pol H.E., Schnack H.G., Cahn W., Mandl R.C., Collins D.L., et al. Focal gray matter changes in schizophrenia across the course of the illness: A 5-year follow-up study. Neuropsychopharmacology 32 (2007) 2057-2066
62. Beninger R.J., Wasserman J., Zanibbi K., Charbonneau D., Mangles J., and Beninger B.V. Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: A double-dissociation. Schizophr Res 61 (2003) 281-292
63. Jönsson E.G., Flyckt L., Burgert E., Crocq M.A., Forslund K., Mattila-Evenden M., et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: Association study and meta-analysis. Psychiatr Genet 13 (2003) 1-12
64. Jönsson E.G., Kaiser R., Brockmöller J., Nimgaonkar V.L., and Crocq M.A. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia. Psychiatr Genet 14 (2004) 9-12
65. Landwehrmeyer B., Mengod G., and Palacios J.M. Dopamine D3 receptor mRNA and binding sites in human brain. Brain Res Mol Brain Res 18 (1993) 187-192
66. Murray A.M., Ryoo H.L., Gurevich E., and Joyce J.N. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci U S A 91 (1994) 11271-11275
67. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., and Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347 (1990) 146-151
68. Okubo Y., Olsson H., Ito H., Lofti M., Suhara T., Halldin C., and Farde L. PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457. Neuroimage 10 (1999) 666-674
69. Frank M.J., Moustafa A.A., Haughey H., Curran T., and Hutchison K.E. Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proc Natl Acad Sci U S A 104 (2007) 16311-16316
70. Talkowski M.E., Kirov G., Bamne M., Georgieva L., Torres G., Mansour H., et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum Mol Genet 17 (2008) 747-758